Drug Monitoring, Methylphenidate Metabolite, Quantitative, Urine

There are no preparation instructions.

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Medmatch Ritalinic Acid

Ritalinic Acid

*Important Information on Lab Test Processing Times: Ulta Lab Tests is committed to informing you about the processing times for your lab tests processed through a national lab. Please note that the estimated processing time for each test, indicated in business days, is based on data from the past 30 days across the 13 laboratories for each test. These estimates are intended to serve as a guide and are not guarantees. Factors such as laboratory workload, weather conditions, holidays, and the need for additional testing or maintenance can influence actual processing times. We aim to offer estimates to help you plan accordingly. Please understand that these times may vary, and processing times are not guaranteed. Thank you for choosing Ulta Lab Tests for your laboratory needs.

The Drug Monitoring, Methylphenidate Metabolite, Quantitative, Urine test contains 1 test with 2 biomarkers.

Drug Monitoring, Methylphenidate Metabolite, Quantitative, Urine

Clinical Significance
Drug Monitoring, Methylphenidate Metabolite, Quantitative, Urine - Methylphenidate is a mild CNS stimulant used to control symptoms of attention deficit hyperactivity disorder (ADHD) in adults and children. Ritalin acid is the metabolite of methylphenidate, and its detection is indicative of ingestion of methylphenidate. The test is a definitive assay using liquid chromatography mass spectroscopy (LC/MS/MS) methodology. Therapeutic urine drug monitoring of methylphenidate is important for ensuring compliance to treatment strategies. Urine or oral fluid are the specimens of choice for routine monitoring of patients taking prescription drugs. Use of serum/plasma should be limited to anuretic patients, or where a patient's clinical appearance does not coincide with their prescribed medications. No single monitoring approach provides adequate information about the pattern or dose of patient drug use. Safest prescribing habits should include a combination of tools and laboratory test results to correctly detect drug use patterns. Quantitative values cannot be used to assess the drug dose, because the drug is extensively metabolized and excreted in the urine.

Includes
If you require medMATCH for this order code, you must also order code 39158 - Prescribed Drugs, medMATCH®. If 39158 is ordered, all Drug Monitoring order codes will be treated as medMATCH.
 
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
Ritalinic Acid

Reference Range(s)
Ritalinic Acid    <100 ng/mL

Alternative Name(s)
Prescription Drug Monitoring,Pain Management

Customer Reviews